Glycogen synthase kinase-3beta is associated with Parkinson's disease
Authors:
- Masahiro NagaoMasahiro Nagao
- Hideaki HayashiHHHideaki Hayashi
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 449 (2) , 103-107
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences, 2008
- Localization of Parkinson’s disease-associated LRRK2 in normal and pathological human brainBrain Research, 2007
- Highly Potent and Specific GSK‐3β Inhibitors That Block Tau Phosphorylation and Decrease α‐Synuclein Protein Expression in a Cellular Model of Parkinson's DiseaseChemMedChem, 2006
- Glycogen Synthase Kinase 3β Modulates Synphilin-1 Ubiquitylation and Cellular Inclusion Formation by SIAHJournal of Biological Chemistry, 2005
- RETRACTED: Glycogen synthase kinase 3β (GSK3β) mediates 6‐ hydroxydopamine‐induced neuronal deathThe FASEB Journal, 2004
- The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's diseaseBrain, 2004
- Synphilin-1 is present in Lewy bodies in Parkinson's diseaseAnnals of Neurology, 2000